These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 21912777)

  • 21. Understanding the inter-relationship between improved glycaemic control, hypoglycaemia and weight change within a long-term economic model.
    McEwan P; Evans M; Kan H; Bergenheim K
    Diabetes Obes Metab; 2010 May; 12(5):431-6. PubMed ID: 20415691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycemic control in type 2 diabetes mellitus.
    Quevedo SF; Westrick E
    Med Health R I; 1998 Nov; 81(11):345-8. PubMed ID: 15580787
    [No Abstract]   [Full Text] [Related]  

  • 23. Options for intensifying diabetes treatment.
    Reid TS
    J Fam Pract; 2011 Sep; 60(9 Suppl):S7-10. PubMed ID: 21912777
    [No Abstract]   [Full Text] [Related]  

  • 24. [Metformin efficacious in poorly controlled diabetes mellitus type 2].
    Stades AM; Holleman F; Hoekstra JB
    Ned Tijdschr Geneeskd; 2000 Sep; 144(40):1897-900. PubMed ID: 11045134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DPP-4 inhibitors in the management of type 2 diabetes: a critical review of head-to-head trials.
    Scheen AJ
    Diabetes Metab; 2012 Apr; 38(2):89-101. PubMed ID: 22197148
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glyburide/metformin HCl clinical overview.
    Seymour A
    Manag Care; 2001 Feb; 10(2 Suppl):11-6. PubMed ID: 11729403
    [No Abstract]   [Full Text] [Related]  

  • 27. Overview of insulin replacement therapy.
    Wright EE
    J Fam Pract; 2009 Aug; 58(8 Suppl):S3-9. PubMed ID: 19679029
    [No Abstract]   [Full Text] [Related]  

  • 28. Cost-effectiveness of rosiglitazone combination therapy for the treatment of type 2 diabetes mellitus in the UK.
    Beale S; Bagust A; Shearer AT; Martin A; Hulme L
    Pharmacoeconomics; 2006; 24 Suppl 1():21-34. PubMed ID: 16800160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diabetes type 2 in pediatrics: diagnosis and management].
    Girardin CM; Schwitzgebel VM
    Rev Med Suisse; 2007 Apr; 3(107):1001-5. PubMed ID: 17526374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in oral therapy for type 2 diabetes.
    Davis SN
    Postgrad Med; 2000 May; 107(6 Suppl Key):16-20. PubMed ID: 19667506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Medications for the Treatment of Diabetes.
    Garg SK; Brackett S; Reinicke T; Hirsch IB
    Diabetes Technol Ther; 2020 Feb; 22(S1):S149-S173. PubMed ID: 32069157
    [No Abstract]   [Full Text] [Related]  

  • 32. Risks and benefits of attaining HbA(1c) goals: examining the evidence.
    Shubrook JH
    J Am Osteopath Assoc; 2010 Jul; 110(7 Suppl 7):eS7-12. PubMed ID: 20644204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dispelling myths and removing barriers about insulin in type 2 diabetes.
    Meece J
    Diabetes Educ; 2006; 32(1 Suppl):9S-18S. PubMed ID: 16439485
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis.
    Gross JL; Kramer CK; Leitão CB; Hawkins N; Viana LV; Schaan BD; Pinto LC; Rodrigues TC; Azevedo MJ;
    Ann Intern Med; 2011 May; 154(10):672-9. PubMed ID: 21576535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycemic Control for Patients With Type 2 Diabetes Mellitus: Our Evolving Faith in the Face of Evidence.
    Rodríguez-Gutiérrez R; Montori VM
    Circ Cardiovasc Qual Outcomes; 2016 Sep; 9(5):504-12. PubMed ID: 27553599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obviating much of the need for insulin therapy in type 2 diabetes mellitus: A re-assessment of insulin therapy's safety profile.
    Schwartz SS; Jellinger PS; Herman ME
    Postgrad Med; 2016 Aug; 128(6):609-19. PubMed ID: 27210018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug evaluation: vildagliptin-metformin single-tablet combination.
    Tahrani AA; Piya MK; Barnett AH
    Adv Ther; 2009 Feb; 26(2):138-54. PubMed ID: 19288260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [HbA1c 8.5% in elderly people with diabetes: is it good enough?].
    Bottermann P
    MMW Fortschr Med; 2009 Jun; 151(26-29):38-9. PubMed ID: 19739547
    [No Abstract]   [Full Text] [Related]  

  • 39. Early combination therapy for the treatment of type 2 diabetes mellitus: systematic review and meta-analysis.
    Phung OJ; Sobieraj DM; Engel SS; Rajpathak SN
    Diabetes Obes Metab; 2014 May; 16(5):410-7. PubMed ID: 24205921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of rosiglitazone oral combination for the treatment of type 2 diabetes in Germany.
    Shearer AT; Bagust A; Liebl A; Schoeffski O; Goertz A
    Pharmacoeconomics; 2006; 24 Suppl 1():35-48. PubMed ID: 16800161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.